SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-19-294735
Filing Date
2019-11-18
Accepted
2019-11-18 16:32:31
Documents
48
Period of Report
2019-11-18

Document Format Files

Seq Description Document Type Size
1 6-K d834167d6k.htm 6-K 15178
2 EX-99.1 d834167dex991.htm EX-99.1 211129
3 EX-99.2 d834167dex992.htm EX-99.2 103069
4 EX-99.3 d834167dex993.htm EX-99.3 86143
11 GRAPHIC g834167g94z19.jpg GRAPHIC 3208
  Complete submission text file 0001193125-19-294735.txt   2220150

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT asnd-20191118.xml EX-101.INS 405867
6 XBRL TAXONOMY EXTENSION SCHEMA asnd-20191118.xsd EX-101.SCH 27692
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE asnd-20191118_cal.xml EX-101.CAL 30391
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE asnd-20191118_def.xml EX-101.DEF 76358
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE asnd-20191118_lab.xml EX-101.LAB 192049
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asnd-20191118_pre.xml EX-101.PRE 151743
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 191227962
SIC: 2834 Pharmaceutical Preparations